
News|Articles|March 1, 2005
First-time generic approvals
Potassium iodide oral solution 65 mg/mL
Advertisement
Potassium iodide oral solution 65 mg/mL (equiv to Thyrosafe tablets 65 mg)
FLEMING & COMPANY
Terconazole vaginal cream 0.4% (equiv to Terazole 7 Vaginal Cream)
TARO
Estradiol transdermal system 0.025 mg/d and 0.075 mg/d (equiv to Climara)
MYLAN
Levofloxacin tablets 750 mg (equiv to Levaquin tablets)
TEVA
Desmopressin nasal solution 0.01% (equiv to DDAVP nasal spray)
APOTEX
Fentanyl transdermal systems 25 mcg/h, 50 mcg/h, 75 mcg/h, and 100 mcg/h (equiv to Duragesic transdermal systems)
MYLAN
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5


























